Literature DB >> 16425410

Changes in lipid metabolism in chronic hepatitis C.

Katalin Jármay1, Gizella Karácsony, András Nagy, Zsuzsa Schaff.   

Abstract

AIM: To investigate the relationship between certain biochemical parameters of lipid metabolism in the serum and steatosis in the liver.
METHODS: The grade of steatosis (0-3) and histological activity index (HAI, 0-18) in liver biopsy specimens were correlated with serum alanine aminotransferase (ALT), total cholesterol and triglyceride levels in 142 patients with chronic hepatitis C (CH-C), and 28 patients with non-alcoholic fatty liver disease (NAFLD) without hepatitis C virus (HCV) infection. The serum parameters were further correlated with 1,797 age and sex matched control patients without any liver diseases.
RESULTS: Steatosis was detected in 90 out of 142 specimens (63%) with CH-C. The ALT levels correlated with the grade of steatosis, both in patients with CH-C and NAFLD (P<0.01). Inserting the score values of steatosis as part of the HAI, correlation with the ALT level (P<0.00001) was found. The triglyceride and cholesterol levels were significantly lower in patients with CH-C (with and without steatosis), compared to the NAFLD group and to the virus-free control groups.
CONCLUSION: Our study confirms the importance of liver steatosis in CH-C which correlates with lower lipid levels in the sera. Inclusion of the score of steatosis into HAI, in case of CH-C might reflect the alterations in the liver tissue more precisely, while correlating with the ALT enzyme elevation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425410      PMCID: PMC4355780          DOI: 10.3748/wjg.v11.i41.6422

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  The pathology of hepatitis C.

Authors:  P J Scheuer; P Ashrafzadeh; S Sherlock; D Brown; G M Dusheiko
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

2.  Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients.

Authors:  E Giannini; P Ceppa; F Botta; A Fasoli; P Romagnoli; E Cresta; V Venturino; D Risso; G Celle; R Testa
Journal:  Liver       Date:  1999-10

Review 3.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

4.  Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.

Authors:  R Thomssen; S Bonk; A Thiele
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

5.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

Authors:  J M Petit; J B Bour; C Galland-Jos; A Minello; B Verges; M Guiguet; J M Brun; P Hillon
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

6.  Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

Authors:  Jason M Hui; James Kench; Geoffrey C Farrell; Rita Lin; Dev Samarasinghe; Christopher Liddle; Karen Byth; Jacob George
Journal:  J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 4.029

7.  Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C.

Authors:  T Asselah; N Boyer; M-C Guimont; D Cazals-Hatem; F Tubach; K Nahon; H Daïkha; D Vidaud; M Martinot; M Vidaud; C Degott; D Valla; P Marcellin
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

8.  Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.

Authors:  Johan Westin; Hans Nordlinder; Martin Lagging; Gunnar Norkrans; Rune Wejstål
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

9.  Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group.

Authors:  J H Lefkowitch; E R Schiff; G L Davis; R P Perrillo; K Lindsay; H C Bodenheimer; L A Balart; T J Ortego; J Payne; J L Dienstag
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

10.  Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.

Authors:  Alexander Monto; Judy Alonzo; Jessica J Watson; Carl Grunfeld; Teresa L Wright
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425

View more
  14 in total

1.  Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

Authors:  Josephine H Li; Xiang Qian Lao; Hans L Tillmann; Jennifer Rowell; Keyur Patel; Alexander Thompson; Sunil Suchindran; Andrew J Muir; John R Guyton; Stephen D Gardner; John G McHutchison; Jeanette J McCarthy
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

2.  Metabolic profiles in patients with chronic hepatitis C: a case-control study.

Authors:  Ching-Sheng Hsu; Chun-Jen Liu; Chen-Hua Liu; Chi-Ling Chen; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2008-02-28       Impact factor: 6.047

3.  Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.

Authors:  Gabor Lendvai; Katalin Jármay; Gizella Karácsony; Tünde Halász; Ilona Kovalszky; Kornélia Baghy; Tibor Wittmann; Zsuzsa Schaff; András Kiss
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.

Authors:  Ornit Chiba-Falek; Colton Linnertz; John Guyton; Stephen D Gardner; Allen D Roses; Jeanette J McCarthy; Keyur Patel
Journal:  Hum Genet       Date:  2012-08-17       Impact factor: 4.132

5.  Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.

Authors:  Mary A Rodgers; Valerie A Villareal; Esperance A Schaefer; Lee F Peng; Kathleen E Corey; Raymond T Chung; Priscilla L Yang
Journal:  J Am Chem Soc       Date:  2012-04-11       Impact factor: 15.419

Review 6.  Targeting host factors: a novel rationale for the management of hepatitis C virus.

Authors:  Mahmoud Aboelneen Khattab
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

7.  Effect of liver steatosis on therapeutic response in chronic hepatitis C virus genotype 1 infected patients in hungary.

Authors:  Klara Werling; Zsuzsa Schaff; Elek Dinya; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2009-09-15       Impact factor: 3.201

8.  Hepatitis C virus infection and the risk of coronary disease.

Authors:  Adeel A Butt; Wang Xiaoqiang; Matthew Budoff; David Leaf; Lewis H Kuller; Amy C Justice
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

9.  Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.

Authors:  Ahlam M Ahmed; Magda S Hassan; Alaa Abd-Elsayed; Huwayda Hassan; Ahmad F Hasanain; Ahmed Helmy
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

10.  Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.

Authors:  Ahmad Fouad; Dina Sabry; Rasha Ahmed; Manal Kamal; Sayed Abd Allah; Samar Marzouk; Mona Amin; Rokaya Abd El Aziz; Ahmad El Badri; Hany Khattab; Dina Helmy
Journal:  Int J Gen Med       Date:  2013-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.